Abstract
Purpose of review
A high proportion of head and neck cancer (HNC) patients use complementary and alternative medicine (CAM), however, healthcare professionals generally have little knowledge about the safety and efficacy of these therapies. The purpose of this study was to determine the quantity and assess the quality of CAM recommendations across clinical practice guidelines (CPGs) for the treatment and/or management of HNC.
Recent findings
MEDLINE, EMBASE, and CINAHL were systematically searched for HNC CPGs published between 2009 and April 2020; the Guidelines International Network and the National Center for Complementary and Integrative Health websites were also were searched. Eligible CPGs containing CAM recommendations were assessed twice with the Appraisal of Guidelines, Research and Evaluation II (AGREE II) instrument, once for the overall CPG and once for the CAM sections. Of 305 unique search results, 7 CPGs mentioned CAM and 4 CPGs made CAM recommendations. The overall CPG scored higher than the CAM section for 4 of 6 domains (overall, CAM): scope and purpose (93.8%, 93.8%), clarity of presentation (88.2%, 64.6%), stakeholder involvement (68.8%, 39.6%), rigor of development (58.3%, 34.6%), editorial independence (42.7%, 42.7%), and applicability (51.6%, 19.8%). Quality varied within and between CPGs.
Summary
Highly scoring CPGs serve as evidence-based resources that clinicians can use to inform their patients about safe and effective CAM use; CPGs achieving variable or lower scores could be improved in future updates based on currently available guideline development/implementation tools. Future research should identify CAM therapies supported by sufficient evidence to be included as part of HNC CPGs.
Similar content being viewed by others
Data Availability
All relevant data are included in this manuscript.
Abbreviations
- AGREE II:
-
Appraisal of Guidelines for Research & Evaluation II
- CAM:
-
complementary and alternative medicine
- CIM:
-
complementary and integrative medicine
- CPG:
-
clinical practice guideline
- HNC:
-
head and neck cancer
- NCCIH:
-
National Center for Complementary and Integrative Health
- PICO:
-
Patients, Intervention, Comparison and Outcomes
- PRISMA:
-
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Head and neck cancer guide. Cancer.Net Doctor Approved Patient Information from ASCO. 2020. https://www.cancer.net/cancer-types/head-and-neck-cancer/introduction. Accessed 14 Jun 2020.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Vigneswaran N, Williams MD. Epidemiological trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014;26(2):123–41.
•• Matovina C, Birkeland AC, Zick S, Shuman AG. Integrative medicine in head and neck cancer. Otolaryngol Head Neck Surg. 2017;156(2):228–37 This article synthesized recently published data to illustrate the decision-making inherent in the use of integrative medicine among patients with head and neck cancer, to address the ethical issues inherent in combining integrative and traditional treatment methods, and to highlight available tools to enhance awareness of integrative medicine by the providers of head and neck cancer. It also provides important implications for practice.
Complementary, alternative, or integrative health: What’s in a name? National Institutes of Health, National Centre for Complementary and Integrative Health (NCCIH). 2016. https://nccih.nih.gov/health/integrative-health. Accessed 14 Jun 2020.
Miller MC, Pribitkin EA, Difabio T, Keane WM. Prevalence of complementary and alternative medicine use among a population of head and neck cancer patients: a survey-based study. Ear Nose Throat J. 2010;89(10):E23–7.
Vyas T, Hart RD, Trites JR, Philips TJ, Archibald KEM, Phillips JE, et al. Complementary and alternative medicine use in patients presenting to a head and neck oncology clinic. Head Neck. 2010;32(6):793–9.
Molassiotis A, Ozden G, Platin N, Scott JA, Pud D, Fernandez-Ortega P, et al. Complementary and alternative medicine use in patients with head and neck cancers in Europe. Eur J Cancer Care. 2006;15:19–24.
Hendershot KA, Dixon M, Kono SA, Shin DM, Pentz RD. Patients’ perceptions of complementary and alternative medicine in head and neck cancer: a qualitative, pilot study with clinical implications. Complement Ther Clin Pract. 2014;20(4):213–8.
Clinical practice guideline manual. American Academy of Family Physicians (AAFP). 2017. https://www.aafp.org/patient-care/clinical-recommendations/cpg-manual.html. Accessed 23 Jun 2020.
•• Anaya MVM, Franco JV, Merchan-Glavis AM, Gallardo CR, Cosp XB. Quality assessment of clinical practice guidelines on treatments for oral cancer. Cancer Treat Rev. 2018;65:47–53 This article is the first to provide a quality assessment of clinical practice guidelines for the treatment of oral cancer. This study is the only one to assess a subset of head and neck cancer clinical practice guidelines to date, finding that in general, the quality of the guidelines assessed was suboptimal.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. https://handbook-5-1.cochrane.org. Accessed 30 Jun 2020.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182(18):E839–42.
Nekhlyudov L, Lacchetti C, Davis NB, Garvey TQ, Goldstein DP, Nunnink JC, et al. Head and neck cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement of the American Cancer Society guideline. J Clin Oncol. 2017;35(14):1606–21.
Choo PK, Ahmad A, Hassan F, Yusoff FM, Kamaruzaman HF, Kassim KNBM, Han KM, Yusof MAM, Noor MKM et al. Management of Nasopharyngeal Carcinoma. Malaysia Health Technology Assessment Section (MaHTAS). 2016. Available from: https://www.researchgate.net/publication/316033175_Clinical_Practice_Guidelines_CPG_on_Management_of_Nasopharyngeal_Carcinoma. Accessed 29 Jun 2020.
Cocks H, Ah-See K, Capel M, Taylor P. Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(Suppl. 2):S198–207.
Cohen EEW, LaMonte SJ, Erb NL, Beckman KL, Sadeghi N, Hutcheson KA, et al. American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66(3):203–39.
Talwar B, Donnelly R, Skelly R, Donaldson M. Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(Suppl. 2):S142–9.
Cuny F, Babin E, Lacau-Saint-Guily J, Baujat B, Bensadoun R, Bozec A, et al. French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132:205–8.
Pfister DG, Ang K-K, Brizel D, Burtness BA, Busse PM, Caudell JJ, et al. Head and neck cancers. J Natl Compr Cancer Netw. 2011;9(6):596–650.
• Ng JY, Nault H, Nazir Z. Complementary and integrative medicine mention and recommendations: a systematic review and quality assessment of lung cancer clinical practice guidelines. Integr Med Res. 2020:100452. https://doi.org/10.1016/j.imr.2020.100452. This article is the first to provide a systematic review of complementary and integrative medicine recommendations and conduct a quality assessment across clinical practice guidelines for the treatment and/or management of lung cancer. Finding very few recommendations overall, this study highlights a major knowledge gap, which may hinder informed shared-decision making between practitioner and provider regarding safe and effective CAM use, especially provided that most healthcare practitioners in oncology have little to no training in this topic area.
Ng JY, Sharma AE. Guidelines for Cancer‐Related Pain: A Systematic Review of Complementary and Alternative Medicine Recommendations. Pain Practice. 2020 Nov 16. https://doi.org/10.1111/papr.12964
• Ng JY, Thakar H. Complementary and alternative medicine mention and recommendations are lacking in colon cancer clinical practice guidelines: A systematic review. Adv Integr Med. 2020. https://doi.org/10.1016/j.aimed.2020.06.002. This article is the first to provide a systematic review of complementary and alternative medicine recommendations and conduct a quality assessment across clinical practice guidelines for the treatment and/or management of colon cancer. Finding no recommendations overall, this study highlights a major knowledge gap, which may hinder informed shared-decision making between practitioner and provider regarding safe and effective CAM use, especially provided that most healthcare practitioners in oncology have little to no training in this topic area.
Ng JY, Lau SK. Complementary and alternative medicine status in ovarian cancer guidelines: A systematic review. European Journal of Integrative Medicine. 2020 Oct 17:101227. https://doi.org/10.1016/j.eujim.2020.101227
Ng JY, Mohiuddin U. Quality of complementary and alternative medicine recommendations in low back pain guidelines: a systematic review. Eur Spine J. 2020;29:1833–44. https://doi.org/10.1007/s00586-020-06393-9.
Ng JY, Liang L, Gagliardi AR. The quantity and quality of complementary and alternative medicine clinical practice guidelines on herbal medicines, acupuncture and spinal manipulation: systematic review and assessment using AGREE II. BMC Complement Altern Med. 2016;16(425):1.
Warrick PD, Irish JC, Morningstar M, Gilbert R, Brown D, Gullane P. Use of alternative medicine among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1999;125(5):573–9.
Schünemann H, Brożek J, Guyatt G, Oxman A (editors). GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group. 2013. Available from: guidelinedevelopment.org/handbook. Accessed 30 Jun 2020.
Treweek S, Oxman AD, Alderson P, Bossuyt PM, Brandt L, Brożek J, et al. Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results. Implement Sci. 2013;8:6.
Shiffman RN, Michel G, Rosenfeld RM, Davidson C. Building better guidelines with BRIDGE-wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability. J Am Med Inform Assoc. 2012;19(1):94–101.
Shiffman RN, Dixon J, Brandt C, Essaihi A, Hsiao A, Michel G, et al. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak. 2005;5(1):23.
Shiffman RN. GuideLines into DEcision support (GLIDES). In: Center for Medical Informatics. Yale School of Medicine. Updated 2019. Available at: https://medicine.yale.edu/cmi/glides/about_glides/. Accessed 30 Jun 2020.
Tools. In: Library& Resources / Tools. Guidelines International Network. 2020. Available from https://g-i-n.net/library/tools. Accessed 30 Jun 2020.
Acknowledgments
We gratefully acknowledge Manav Nayeni for assisting with screening and data extraction.
Funding
JYN was funded by a Research Scholarship and an Entrance Scholarship from the Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences at McMaster University.
Author information
Authors and Affiliations
Contributions
JYN: designed and conceptualized the study, collected and analysed data, co-drafted the manuscript, and gave final approval of the version to be published.
ED: assisted with the collection and analysis of data, co-drafted the manuscript, and gave final approval of the version to be published.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
This study involved a systematic review of peer-reviewed literature only; it did not require ethics approval or consent to participate.
Consent for Publication
All authors consent to this manuscript’s publication.
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Integrative Care
Supplementary Information
Supplementary File 1
MEDLINE Search Strategy for HNC CPGs Executed April 17th, 2020 (DOCX 26 kb).
Supplementary File 2
Modified AGREE II Questions Used to Guide Scoring of CAM Sections of Each CPG. Note: All Supplementary Files were created by the authors and do not require permission to reproduce (XLSX 14 kb).
Rights and permissions
About this article
Cite this article
Ng, J.Y., Dogadova, E. The Presence of Complementary and Alternative Medicine Recommendations in Head and Neck Cancer Guidelines: Systematic Review and Quality Assessment. Curr Oncol Rep 23, 32 (2021). https://doi.org/10.1007/s11912-021-01024-y
Accepted:
Published:
DOI: https://doi.org/10.1007/s11912-021-01024-y